BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 12296995)

  • 41. Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells.
    Takada Y; Sethi G; Sung B; Aggarwal BB
    Mol Pharmacol; 2008 May; 73(5):1549-57. PubMed ID: 18287248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2.
    Song HY; Régnier CH; Kirschning CJ; Goeddel DV; Rothe M
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9792-6. PubMed ID: 9275204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of stress-activated protein kinase/c-Jun N-terminal kinase, but not NF-kappaB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway.
    Shi CS; Kehrl JH
    J Biol Chem; 1997 Dec; 272(51):32102-7. PubMed ID: 9405407
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
    Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
    Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
    Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kaposi's sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK/AP1 pathways.
    An J; Sun Y; Sun R; Rettig MB
    Oncogene; 2003 May; 22(22):3371-85. PubMed ID: 12776188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit.
    Jang HD; Yoon K; Shin YJ; Kim J; Lee SY
    J Biol Chem; 2004 Jun; 279(23):24873-80. PubMed ID: 15140884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways.
    Hu WH; Johnson H; Shu HB
    J Biol Chem; 1999 Oct; 274(43):30603-10. PubMed ID: 10521444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.
    Jiang Z; Ninomiya-Tsuji J; Qian Y; Matsumoto K; Li X
    Mol Cell Biol; 2002 Oct; 22(20):7158-67. PubMed ID: 12242293
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TAK1 is essential for osteoclast differentiation and is an important modulator of cell death by apoptosis and necroptosis.
    Lamothe B; Lai Y; Xie M; Schneider MD; Darnay BG
    Mol Cell Biol; 2013 Feb; 33(3):582-95. PubMed ID: 23166301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. VP4 differentially regulates TRAF2 signaling, disengaging JNK activation while directing NF-kappa B to effect rotavirus-specific cellular responses.
    LaMonica R; Kocer SS; Nazarova J; Dowling W; Geimonen E; Shaw RD; Mackow ER
    J Biol Chem; 2001 Jun; 276(23):19889-96. PubMed ID: 11262403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ras and mitogen-activated protein kinase kinase kinase-1 coregulate activator protein-1- and nuclear factor-kappaB-mediated gene expression in airway epithelial cells.
    Zhou L; Tan A; Iasvovskaia S; Li J; Lin A; Hershenson MB
    Am J Respir Cell Mol Biol; 2003 Jun; 28(6):762-9. PubMed ID: 12600818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reciprocal inhibition between the transforming growth factor-β-activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) mitogen-activated protein kinase kinase kinases and its suppression by TAK1-binding protein 2 (TAB2), an adapter protein for TAK1.
    Kim SY; Shim JH; Chun E; Lee KY
    J Biol Chem; 2012 Jan; 287(5):3381-91. PubMed ID: 22167179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs.
    Pullen SS; Dang TT; Crute JJ; Kehry MR
    J Biol Chem; 1999 May; 274(20):14246-54. PubMed ID: 10318845
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of transforming growth factor-activated kinase-1 on tumor necrosis factor-α actions in human adipose tissue-derived stromal cells.
    Lee SY; Lee JH; Shin KK; Kim DS; Kim YS; Bae YC; Jung JS
    Stem Cells Dev; 2015 Apr; 24(7):836-45. PubMed ID: 25350220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.
    Saeki K; Kobayashi N; Inazawa Y; Zhang H; Nishitoh H; Ichijo H; Saeki K; Isemura M; Yuo A
    Biochem J; 2002 Dec; 368(Pt 3):705-20. PubMed ID: 12206715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells.
    Yoshizumi M; Fujita Y; Izawa Y; Suzaki Y; Kyaw M; Ali N; Tsuchiya K; Kagami S; Yano S; Sone S; Tamaki T
    Exp Cell Res; 2004 Jan; 292(1):1-10. PubMed ID: 14720501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.